Skip to main content
. 2021 Jul 26;10(15):3293. doi: 10.3390/jcm10153293

Table 2.

Bivariant analysis of factors associated with the mention of adverse drug reactions in the discharge reports.

Total
N = 286
ADRs in the Discharge Report p Value
Mentioned
N = 238
Not Mentioned
N = 48
Hospital Assistance Required by the ADRs
Required hospitalization 156 (100) 134 (85.9) 22 (14.1) 0.309
Occurred during hospitalization 109 (100) 86 (78.9) 23 (21.1)
Required emergency care 21 (100) 18 (85.7) 3 (14.3)
Reporting Clinical Service
Intensive care 60 (100) 47 (78.3) 13 (21.7) 0.454
Pediatrics 60 (100) 50 (83.3) 10 (16.7)
Internal medicine 53 (100) 48 (90.6) 5 (9.4)
Cardiology 27 (100) 21 (77.8) 6 (22.2)
Others 86 (100) 72 (83.7) 14 (16.3)
Same Reporting and Discharging Clinical Service
Yes 198 (100) 161 (81.3) 37 (18.7) 0.087
No 88 (100) 64 (72.7) 24 (27.3)
Seriousness of the ADRs
Required/prolonged hospitalization 109(100) 96 (88.1) 13 (11.9) 0.041
Life-threatening/fatal 99 (100) 84 (84.8) 15 (15.2)
Not serious 78 (100) 58 (74.4) 20 (25.6)
At least one Suspected Drug with Inverted Drug Triangle
Yes 39 (100) 31 (79.5) 8 (20.5) 0.493
No 247 (100) 207 (83.8) 40 (16.2)
At Least One Suspected Drug with an Unknown ADRs
Yes 43 (100) 37 (86.0) 6 (14.0) 0.544
No 243 (100) 201 (82.7) 42 (17.3)
Alternative Causes Ruled Out in the Causality Assessment
Yes 249 (100) 218 (87.6) 31 (12.4) <0.001
No 37 * (100) 20 (54.1) 17 (45.9)

* In these reports a possible alternative cause could not be ruled out.